WO2008056377A3 - Polymorphic forms of rimonabant - Google Patents

Polymorphic forms of rimonabant Download PDF

Info

Publication number
WO2008056377A3
WO2008056377A3 PCT/IN2007/000522 IN2007000522W WO2008056377A3 WO 2008056377 A3 WO2008056377 A3 WO 2008056377A3 IN 2007000522 W IN2007000522 W IN 2007000522W WO 2008056377 A3 WO2008056377 A3 WO 2008056377A3
Authority
WO
WIPO (PCT)
Prior art keywords
rimonabant
polymorphic forms
hydratcd
preparation
disclosed
Prior art date
Application number
PCT/IN2007/000522
Other languages
French (fr)
Other versions
WO2008056377A2 (en
Inventor
Mayank Ghanshyambhai Dave
Parind Narendra Dholakia
Bipin Pandey
Pankaj Ramanbhai Patel
Original Assignee
Cadila Healthcare Ltd
Mayank Ghanshyambhai Dave
Parind Narendra Dholakia
Bipin Pandey
Pankaj Ramanbhai Patel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IN1839/MUM/2006 priority Critical
Priority to IN1839MU2006 priority
Priority to IN1846MU2006 priority
Priority to IN1846/MUM/2006 priority
Application filed by Cadila Healthcare Ltd, Mayank Ghanshyambhai Dave, Parind Narendra Dholakia, Bipin Pandey, Pankaj Ramanbhai Patel filed Critical Cadila Healthcare Ltd
Publication of WO2008056377A2 publication Critical patent/WO2008056377A2/en
Publication of WO2008056377A3 publication Critical patent/WO2008056377A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism

Abstract

Disclosed herein are the novel amorphous hydratcd and crystalline forms of Rimonabant, process(s) for their preparation and pharmaceutical compositions containing it.
PCT/IN2007/000522 2006-11-06 2007-11-05 Polymorphic forms of rimonabant WO2008056377A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
IN1839/MUM/2006 2006-11-06
IN1839MU2006 2006-11-06
IN1846MU2006 2006-11-07
IN1846/MUM/2006 2006-11-07

Publications (2)

Publication Number Publication Date
WO2008056377A2 WO2008056377A2 (en) 2008-05-15
WO2008056377A3 true WO2008056377A3 (en) 2008-10-30

Family

ID=39322618

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2007/000522 WO2008056377A2 (en) 2006-11-06 2007-11-05 Polymorphic forms of rimonabant

Country Status (1)

Country Link
WO (1) WO2008056377A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2025674A1 (en) 2007-08-15 2009-02-18 sanofi-aventis Substituted tetra hydro naphthalines, method for their manufacture and their use as drugs

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0656354A1 (en) * 1993-12-02 1995-06-07 Sanofi Substituted N-piperidino 3-pyrazolecarboxamide
WO2003040105A1 (en) * 2001-11-08 2003-05-15 Sanofi-Synthelabo Polymorphous form of rimonabant, preparation method and pharmaceutical compositions containing same
EP1816125A1 (en) * 2006-02-02 2007-08-08 Ranbaxy Laboratories, Ltd. Novel crystalline forms of an antagonist of CB1 cannabinoid receptor and preparation method thereof
WO2007090949A1 (en) * 2006-02-08 2007-08-16 Sanofi-Aventis Rimonabant monohydrate, process for the preparation thereof and pharmaceutical compositions containing same
WO2007103711A2 (en) * 2006-03-01 2007-09-13 Dr. Reddy's Laboratories Ltd. Polymorphic forms of rimonabant
WO2008026219A2 (en) * 2006-09-01 2008-03-06 Hetero Drugs Limited Novel polymorphs of rimonabant
WO2008035023A1 (en) * 2006-09-19 2008-03-27 Cipla Limited Polymorphs of rimonabant
WO2008064615A2 (en) * 2006-12-01 2008-06-05 Zentiva, A.S. Crystalline and amorphous forms of rimonabant and processes for obtaining them

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0656354A1 (en) * 1993-12-02 1995-06-07 Sanofi Substituted N-piperidino 3-pyrazolecarboxamide
WO2003040105A1 (en) * 2001-11-08 2003-05-15 Sanofi-Synthelabo Polymorphous form of rimonabant, preparation method and pharmaceutical compositions containing same
EP1816125A1 (en) * 2006-02-02 2007-08-08 Ranbaxy Laboratories, Ltd. Novel crystalline forms of an antagonist of CB1 cannabinoid receptor and preparation method thereof
WO2007090949A1 (en) * 2006-02-08 2007-08-16 Sanofi-Aventis Rimonabant monohydrate, process for the preparation thereof and pharmaceutical compositions containing same
WO2007103711A2 (en) * 2006-03-01 2007-09-13 Dr. Reddy's Laboratories Ltd. Polymorphic forms of rimonabant
WO2008026219A2 (en) * 2006-09-01 2008-03-06 Hetero Drugs Limited Novel polymorphs of rimonabant
WO2008035023A1 (en) * 2006-09-19 2008-03-27 Cipla Limited Polymorphs of rimonabant
WO2008064615A2 (en) * 2006-12-01 2008-06-05 Zentiva, A.S. Crystalline and amorphous forms of rimonabant and processes for obtaining them

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
COLTMAN, S.C.W. ET AL, SYNTHESIS, 1984, pages 150 - 152, XP002491304 *
HANCOCK B C ET AL: "What is the true solubility advantage for amorphous pharmaceuticals?", PHARMACEUTICAL RESEARCH, NEW YORK, NY, US, vol. 17, no. 4, 1 April 2000 (2000-04-01), pages 397 - 404, XP009086748, ISSN: 0724-8741 *
KOTAGIRI V.K. ET AL, ORGANIC PROCESS RESEARCH & DEVELOPMENT, vol. 11, 2007, pages 910 - 912, XP002491303 *

Also Published As

Publication number Publication date
WO2008056377A2 (en) 2008-05-15

Similar Documents

Publication Publication Date Title
HK1199444A1 (en) Method of preparing 3,7-diamino-10h-phenothiazine compounds 3,7--10h-
EP1740156B8 (en) Method for the production of an abuse-proof, solid form of administration
FR2889526B1 (en) Substituted 7-aza-indazoles, compositions containing same, process for production and use
HK1201822A1 (en) Process for the preparation of 5,6-dihydro-1h-pyridin-2-one compounds 56--1h--2-
ZA200703277B (en) Novel pyrimidine compounds, process for their preparation and compositions containing them
PL1743882T3 (en) Process for the preparation of isocyanates
FR2891826B1 (en) Crystalline form 6 of ivabradine hydrochloride, process for preparing the same, and pharmaceutical compositions containing the same
WO2007089768A3 (en) 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as jak-2 modulators and pharmaceutical compositions containing them
PL1993985T3 (en) Process for the preparation of 1,2-propanediol
DE602006001312D1 (en) Crystalline gamma of ivabradine hydrochloride, process for its preparation and pharmaceutical composition containing the same
WO2009062044A3 (en) Processes for the preparation of prasugrel, and its salts and polymorphs
WO2007146965A3 (en) Compounds for the treatment of periodontal disease
AT397933T (en) Crystalline gamma-d of ivabradine hydrochloride, method for its preparation and pharmaceutical composition containing thereof
DE602006001365D1 (en) Crystalline beta-d of ivabradine hydrochloride, process for its preparation and pharmaceutical composition containing the same
IL196894A (en) Process for preparing 3-dihalomethylpyrazole-4-carboxylic acid derivatives
DE602006002624D1 (en) Crystalline beta of ivabradine hydrochloride, process for its preparation and pharmaceutical composition containing the same
AT522488T (en) Process for the preparation of 1,2-dichlorethane
IL197135A (en) 4-substituted phenoxyphenylacetic acid derivatives, pharmaceutical compositions comprising them, uses thereof and processes for their preparation
ZA200708537B (en) Process for preparing nutritional compositions
FR2903101B1 (en) Novel naphthalenic derivatives, process for their preparation and pharmaceutical compositions containing same
WO2009066326A3 (en) Improved process for the preparation of prasugrel and its pharmaceutically acceptable salts
HRP20170095T1 (en) New crystalline form iii of agomelatin, the process for its preparation and pharmaceutical compositions containing it
WO2004082822A3 (en) Methods for isolating crystalline form i of 5-azacytidine
IL196875D0 (en) Process for the preparation of 2-substituted-5-(1-alkylthio)alkylpyridines
BRPI0617159A2 (en) PI3Ka INHIBITORS PYRIDOPYRIMIDINONE COMPOUNDS, COMPOSITIONS CONTAINING THEM AND PROCESS FOR PREPARATION

Legal Events

Date Code Title Description
DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07870518

Country of ref document: EP

Kind code of ref document: A2

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)